embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

EMBC 11.12.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-26
Name of Upcoming Event:Conference Call
Full Press ReleaseSEC FilingsOur EMBC Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 12.19.2024 - embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
  • 11.26.2024 - Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

Recent Filings

  • 12.19.2024 - ARS Annual Report to Security Holders
  • 12.19.2024 - DEF 14A Other definitive proxy statements
  • 12.19.2024 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
PDF Version135 KB

PARSIPPANY, N.J.,Nov. 12, 2024(GLOBE NEWSWIRE) --Embecta Corp.(“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at8:00 a.m. Eastern Time(ET) onTuesday, November 26, 2024.

Those who would like to participate may access the live webcasthere, or access the teleconferencehere. The live webcast can also be accessed via the company’s website atinvestors.embecta.com.

A webcast replay of the call will be available beginning at11:00 a.m. ETonNov 26, 2024, via the embecta investor relations website and archived on the website for one year.

About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visitembecta.comor follow our social channels onLinkedIn,Facebook, andInstagram.

Contacts:

MediaInvestors
Christian Glazar

Pravesh Khandelwal
Sr. Director, Corporate CommunicationsVP, Head of Investor Relations
908-821-6922551-264-6547
Contact Media RelationsContact IR

Primary Logo

Source: Embecta Corp.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com